Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. SECOND AMENDMENT TO OFFICE LEASE AGREEMENTOffice Lease Agreement • May 17th, 2010 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
THIS SECOND AMENDMENT TO OFFICE LEASE AGREEMENT (this “Amendment”) is entered into between 2525 WEST END, LLC, a Delaware limited liability company (“Landlord”), and CUMBERLAND PHARMACEUTICALS INC., a Tennessee corporation (“Tenant”), with reference to the following:
CUMBERLAND PHARMACEUTICALS INC. 2007 LONG-TERM INCENTIVE COMPENSATION PLAN NON- STATUTORY STOCK OPTION AGREEMENTStock Option Agreement • May 17th, 2010 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
CUMBERLAND PHARMACEUTICALS INC. 2007 LONG-TERM INCENTIVE COMPENSATION PLAN INCENTIVE STOCK OPTION AGREEMENTIncentive Compensation Plan Incentive Stock Option Agreement • May 17th, 2010 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
CUMBERLAND PHARMACEUTICALS INC. 2007 DIRECTORS’ INCENTIVE PLAN NON-STATUTORY STOCK OPTION AGREEMENTIncentive Plan Non-Statutory Stock Option Agreement • May 17th, 2010 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. FOURTH AMENDMENT TO KRISTALOSE AGREEMENTKristalose Agreement • May 17th, 2010 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
This Fourth Amendment to Kristalose Agreement (the “Fourth Amendment”) is effective this 1st day of January, 2010 by and between Inalco S.P.A. (“Inalco Italy”), Inalco Biochemicals, Inc. (“Inalco U.S.”) and Cumberland Pharmaceuticals Inc. (“Cumberland”). Inalco Italy and Inalco U.S. are hereinafter collectively referred to as “Inalco.”
